FMNL1
Basic information
Region (hg38): 17:45221444-45247319
Previous symbols: [ "C17orf1B", "FMNL" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FMNL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 87 | 90 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 87 | 4 | 0 |
Variants in FMNL1
This is a list of pathogenic ClinVar variants found in the FMNL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-45222176-C-T | not specified | Likely benign (Nov 30, 2021) | ||
17-45222183-A-G | not specified | Uncertain significance (May 06, 2024) | ||
17-45230656-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
17-45230658-G-A | not specified | Uncertain significance (Aug 10, 2024) | ||
17-45232473-A-C | not specified | Uncertain significance (Mar 12, 2024) | ||
17-45232474-C-G | not specified | Uncertain significance (Aug 16, 2021) | ||
17-45232479-G-T | not specified | Uncertain significance (Apr 25, 2022) | ||
17-45233257-C-G | not specified | Uncertain significance (May 30, 2024) | ||
17-45233668-A-G | not specified | Uncertain significance (Jan 24, 2025) | ||
17-45233716-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
17-45234091-G-A | not specified | Uncertain significance (Nov 06, 2024) | ||
17-45234119-A-T | not specified | Uncertain significance (Oct 12, 2022) | ||
17-45234175-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
17-45234179-A-G | not specified | Uncertain significance (Sep 30, 2024) | ||
17-45234184-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
17-45236230-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
17-45237592-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
17-45237601-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
17-45238561-C-T | Benign (Dec 31, 2019) | |||
17-45238571-G-C | not specified | Uncertain significance (Aug 01, 2023) | ||
17-45238577-A-C | not specified | Uncertain significance (May 23, 2023) | ||
17-45238609-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
17-45238634-T-A | not specified | Uncertain significance (Aug 17, 2022) | ||
17-45239036-A-G | not specified | Uncertain significance (Dec 09, 2024) | ||
17-45239052-A-G | not specified | Uncertain significance (Dec 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FMNL1 | protein_coding | protein_coding | ENST00000331495 | 26 | 25877 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000148 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.00 | 407 | 616 | 0.660 | 0.0000388 | 7074 |
Missense in Polyphen | 102 | 177.45 | 0.5748 | 1903 | ||
Synonymous | 1.69 | 221 | 255 | 0.865 | 0.0000159 | 2225 |
Loss of Function | 5.88 | 6 | 51.6 | 0.116 | 0.00000265 | 616 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the control of cell motility and survival of macrophages (By similarity). Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics and cell shape. {ECO:0000250, ECO:0000269|PubMed:21834987}.;
- Pathway
- Signal Transduction;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.48
Haploinsufficiency Scores
- pHI
- 0.386
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.615
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.742
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fmnl1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype; cellular phenotype;
Gene ontology
- Biological process
- substrate-dependent cell migration;regulation of cell shape;cortical actin cytoskeleton organization;actin filament severing
- Cellular component
- cytosol;plasma membrane;cell cortex;membrane;bleb;phagocytic vesicle;extracellular exosome
- Molecular function
- molecular_function;protein binding;profilin binding;GTPase activating protein binding;Rac GTPase binding;actin filament binding